Dimaymay, Jenifer .

HRN: 06-29-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2024
CEFUROXIME 500MG (TAB)
07/22/2024
07/29/2024
PO
500mg
BID
S/P NSVD
Waiting Final Action 
07/22/2024
CEFUROXIME 500MG (TAB)
07/22/2024
07/29/2024
PO
500mg
BID
S/P NSVD
Waiting Final Action 
07/23/2024
CEFUROXIME 1.5GM (VIAL)
07/23/2024
07/24/2024
IV
1.5 Grams
Q8
UTI X 3 Doses
Waiting Final Action 
07/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/23/2024
07/30/2024
IV
500 Mg
Q8
UTI X 3 Doses
Waiting Final Action 
07/23/2024
METRONIDAZOLE 500MG (TAB)
07/24/2024
07/31/2024
PO
1 Tab
TID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: